MXPA02009103A - Sistema terapeutico transdermal para la administracion de lerisetron. - Google Patents
Sistema terapeutico transdermal para la administracion de lerisetron.Info
- Publication number
- MXPA02009103A MXPA02009103A MXPA02009103A MXPA02009103A MXPA02009103A MX PA02009103 A MXPA02009103 A MX PA02009103A MX PA02009103 A MXPA02009103 A MX PA02009103A MX PA02009103 A MXPA02009103 A MX PA02009103A MX PA02009103 A MXPA02009103 A MX PA02009103A
- Authority
- MX
- Mexico
- Prior art keywords
- lerisetron
- therapeutic system
- transdermal therapeutic
- delivery
- layer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Un preparado farmaceutico que contiene Lerisetron en forma de un sistema terapeutico transdermal (STT), el cual esta constituido por una capa superior, una reserva adhesivo de principio activo que contiene Lerisetron de al menos una capa unido a la capa superior, formado por uno o varios adhesivos de contacto de silicona, y una capa protectora amovible.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10015783A DE10015783C2 (de) | 2000-03-30 | 2000-03-30 | Transdermales therapeutisches System zur Abgabe von Lerisetron und seine Verwendung |
PCT/EP2001/003089 WO2001074338A1 (de) | 2000-03-30 | 2001-03-17 | Transdermales therapeutisches system zur abgabe von lerisetron |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA02009103A true MXPA02009103A (es) | 2004-08-12 |
Family
ID=7636948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02009103A MXPA02009103A (es) | 2000-03-30 | 2001-03-17 | Sistema terapeutico transdermal para la administracion de lerisetron. |
Country Status (16)
Country | Link |
---|---|
US (1) | US20040001881A1 (es) |
EP (1) | EP1267846B1 (es) |
JP (1) | JP2003528912A (es) |
KR (1) | KR100624500B1 (es) |
AR (1) | AR028525A1 (es) |
AT (1) | ATE310510T1 (es) |
AU (1) | AU782487B2 (es) |
BR (1) | BR0109893A (es) |
CA (1) | CA2403949C (es) |
DE (2) | DE10015783C2 (es) |
ES (1) | ES2254425T3 (es) |
HU (1) | HUP0204448A3 (es) |
IL (2) | IL151922A0 (es) |
MX (1) | MXPA02009103A (es) |
NZ (1) | NZ521099A (es) |
WO (1) | WO2001074338A1 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040002482A1 (en) * | 2000-08-30 | 2004-01-01 | Dudley Robert E. | Androgen pharmaceutical composition and method for treating depression |
US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
US20040092494A9 (en) * | 2000-08-30 | 2004-05-13 | Dudley Robert E. | Method of increasing testosterone and related steroid concentrations in women |
WO2003100091A1 (en) * | 2002-05-24 | 2003-12-04 | Epidauros Biotechnologie Ag | Means and methods for improved treatment using 'setrones' |
GB0302662D0 (en) | 2003-02-05 | 2003-03-12 | Strakan Ltd | Transdermal granisetron |
FR2851470B1 (fr) * | 2003-02-20 | 2007-11-16 | Besins Int Belgique | Composition pharmaceutique pour administration transdermique ou transmuqueuse |
KR20070072867A (ko) * | 2004-09-01 | 2007-07-06 | 넥스메드 홀딩스 인코포레이티드 | 경피성 항구토 전달 시스템, 이의 방법 및 조성물 |
DE102004044578A1 (de) | 2004-09-13 | 2006-03-30 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System mit einer Haftschicht, Verfahren zum Silikonisieren einer Rückschicht des Systems und Verwendung der Rückschicht |
US20060263421A1 (en) | 2005-05-18 | 2006-11-23 | Abeille Pharmaceuticals Inc | Transdermal Method and Patch for Nausea |
ZA200803087B (en) | 2005-10-12 | 2009-11-25 | Unimed Pharmaceuticals Llc | Improved testosterone gel and method of use |
CA2705965A1 (en) | 2007-11-22 | 2009-05-28 | Medrx Co., Ltd. | External preparation composition comprising fatty acid-based ionic liquid as active ingredient |
FR2943253B1 (fr) * | 2009-03-20 | 2011-04-22 | Oreal | Composition contenant l'association de madecassoside, d'une arginine et de polysorbate |
JP5681883B2 (ja) * | 2009-03-27 | 2015-03-11 | 株式会社 メドレックス | 核酸を有効成分とする外用剤組成物 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3315272C2 (de) * | 1983-04-27 | 1986-03-27 | Lohmann Gmbh & Co Kg, 5450 Neuwied | Pharmazeutisches Produkt und Verfahren zu seiner Herstellung |
US5486362A (en) * | 1991-05-07 | 1996-01-23 | Dynagen, Inc. | Controlled, sustained release delivery system for treating drug dependency |
US5256665A (en) * | 1991-05-10 | 1993-10-26 | Fabrica Espanola De Productos Quimicos Y Farmaceuticos, S.A. | Process for preparing new 2-piperazinylbenzimidazole |
US5989586A (en) * | 1992-10-05 | 1999-11-23 | Cygnus, Inc. | Two-phase matrix for sustained release drug delivery device |
JPH10167956A (ja) * | 1996-12-11 | 1998-06-23 | Hisamitsu Pharmaceut Co Inc | セロトニン受容体拮抗薬含有経皮投与製剤 |
IT1294748B1 (it) * | 1997-09-17 | 1999-04-12 | Permatec Tech Ag | Formulazione per un dispositivo transdermico |
GB9721139D0 (en) * | 1997-10-07 | 1997-12-03 | Glaxo Group Ltd | Medicaments |
US6136807A (en) * | 1998-11-10 | 2000-10-24 | 3M Innovative Properties Company | Composition for the transdermal delivery of lerisetron |
-
2000
- 2000-03-30 DE DE10015783A patent/DE10015783C2/de not_active Expired - Fee Related
-
2001
- 2001-03-17 KR KR1020027011385A patent/KR100624500B1/ko not_active IP Right Cessation
- 2001-03-17 ES ES01936095T patent/ES2254425T3/es not_active Expired - Lifetime
- 2001-03-17 NZ NZ521099A patent/NZ521099A/en active Application Revival
- 2001-03-17 AT AT01936095T patent/ATE310510T1/de not_active IP Right Cessation
- 2001-03-17 DE DE50108168T patent/DE50108168D1/de not_active Expired - Fee Related
- 2001-03-17 US US10/240,105 patent/US20040001881A1/en not_active Abandoned
- 2001-03-17 BR BR0109893-4A patent/BR0109893A/pt not_active Application Discontinuation
- 2001-03-17 HU HU0204448A patent/HUP0204448A3/hu unknown
- 2001-03-17 IL IL15192201A patent/IL151922A0/xx active IP Right Grant
- 2001-03-17 EP EP01936095A patent/EP1267846B1/de not_active Expired - Lifetime
- 2001-03-17 CA CA002403949A patent/CA2403949C/en not_active Expired - Fee Related
- 2001-03-17 AU AU62107/01A patent/AU782487B2/en not_active Ceased
- 2001-03-17 MX MXPA02009103A patent/MXPA02009103A/es unknown
- 2001-03-17 WO PCT/EP2001/003089 patent/WO2001074338A1/de active IP Right Grant
- 2001-03-17 JP JP2001572083A patent/JP2003528912A/ja not_active Withdrawn
- 2001-03-28 AR ARP010101463A patent/AR028525A1/es unknown
-
2002
- 2002-09-25 IL IL151922A patent/IL151922A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2403949C (en) | 2008-09-16 |
IL151922A0 (en) | 2003-04-10 |
ATE310510T1 (de) | 2005-12-15 |
US20040001881A1 (en) | 2004-01-01 |
WO2001074338A1 (de) | 2001-10-11 |
NZ521099A (en) | 2006-11-30 |
HUP0204448A3 (en) | 2004-07-28 |
EP1267846B1 (de) | 2005-11-23 |
CA2403949A1 (en) | 2002-09-26 |
DE10015783A1 (de) | 2001-10-11 |
IL151922A (en) | 2007-10-31 |
AU782487B2 (en) | 2005-08-04 |
JP2003528912A (ja) | 2003-09-30 |
DE50108168D1 (de) | 2005-12-29 |
AR028525A1 (es) | 2003-05-14 |
BR0109893A (pt) | 2003-04-01 |
EP1267846A1 (de) | 2003-01-02 |
HUP0204448A2 (en) | 2003-05-28 |
DE10015783C2 (de) | 2003-12-04 |
KR20020084161A (ko) | 2002-11-04 |
AU6210701A (en) | 2001-10-15 |
KR100624500B1 (ko) | 2006-09-18 |
ES2254425T3 (es) | 2006-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH31473A (en) | Transdermal therapeutic system comprising galanthamine as active component. | |
DK0802789T3 (da) | Estradiolholdigt plaster | |
MXPA02009103A (es) | Sistema terapeutico transdermal para la administracion de lerisetron. | |
AU4948493A (en) | Dexpanthenol-containing plaster for the transdermal application of steroid hormones | |
DK1355636T3 (da) | Transdermalt terapeutisk system til administrering af carboxylgruppeholdige, ikke-steroidale antiflogistika samt en fremgangsmåde til fremstilling deraf | |
AU2001230193A1 (en) | Transdermal therapeutic system for the administration of zaleplon | |
PL309602A1 (en) | Nitroglycerin container plaster, method of obtaining same and application thereof | |
WO2002017928A3 (de) | Transdermales therapeutisches system zur abgabe von exemestan | |
YU71293A (sh) | Transdermalni terapijski sistem za davanje fizostigmina na koži i postupak za njegovu izradu |